Vasc-Alert LLC’s surveillance technology successfully predicts which dialysis patients are at risk of experiencing stenosis, a study published in the Journal of Vascular Access shows. Patients assigned high scores by the company’s algorithm had seven times the risk of stenosis and blockage compared to those with low-risk scores. Read More
Chinabridge (Shenzhen) Medical Technology Co. Ltd.’s extracorporeal membrane oxygenation (ECMO) machine Lifemotion gained NMPA approval, making it the first domestically developed ECMO unit given a greenlight in China. The approval includes the ECMO machine and the disposable consumables used in combination to treat acute respiratory failure or acute cardiopulmonary failure in seriously ill COVID-19 patients. Read More
Thirona BV spun out its retina division into a stand-alone business, Thirona Retina BV, focused exclusively on the eye disease market, effective Jan. 1, 2023. The development comes after the recent expansion of Retcad, Thirona’s flagship solution for eye disease screening. Thirona BV will continue to develop artificial intelligence (AI)-driven systems for precision medicine in lung disease. Read More
Vaxxas Pty. Ltd. and the Coalition for Epidemic Preparedness Innovations (CEPI) signed a partnership agreement to develop Vaxxas’ vaccine-patch delivery technology in a project that could end the need for frozen storage of mRNA vaccines. Read More
The discovery of two new sarcoma-specific pathways and 14 new genes that predispose people to heritable sarcomas could pave the way to managing cancer risk early via detection of these mutations for this rare type of cancer. Sarcomas are rare connective tissue malignancies mostly derived from embryonic mesoderm and affect younger people. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent, AMF Medical, Appletree CI Biofourmis, Children's Hospital of Philadelphia, Dermtech, Illuminare Biotechnologies, Quest Diagnostics, Ostomycure, Philips, Pixium, Tandem, TFS Healthscience, Viewray, Woebot, Xylyx. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Asensus Surgical, Cardiorenal Systems, Cytosorbents. Read More
